Cytomaite Development of artificial intelligence-driven tools based on cytomorphological analysis for diagnostic and outcome prediction of patients with acute hematological diseases
B-C-ALL- Colony counting for B-cell acute lymphocytic leukemia
Fellowship: Philosophy of Artificial Intelligence for Health
Automated Antibody Design for Targeted Cellular Immunotherapy of Anaplastic Thyroid Cancer
HISTOMAITE: Personalized Medicine: Artificial intelligence augmented intraoperative real time histology for head and neck cancer treatment
Fellowship: Improvement of CAR-T cell therapy through the use of AI
Nanolive: Use of 3D Holotomographic Microscopy on Living Cells as a Novel Source of Data for Deep Learning Analysis in Cancer Research
Fellowship: Ethics for Artificial Intelligence in Health
AI-compatible platform for automated therapeutic target discovery to overcome acquired drug resistance in leukemia
AMLAMO – Automated Machine Learning-Assisted Media Optimization
Funded By Mertelsmann Foundation
The Mertelsmann Foundation has made improving the fight against cancer with the help of innovative methods its main concern. To this end, it brings together cancer research and artificial intelligence. In doing so, it relies on interdisciplinary collaboration between experimental and clinical oncology, artificial intelligence and philosophy.